These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 19413729

  • 1. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-Costes N, Bonin P, Rodet M, Chami B, Galacteros F, Bierling P, Noizat-Pirenne F.
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [Abstract] [Full Text] [Related]

  • 2. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galactéros F, Bierling P.
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [Abstract] [Full Text] [Related]

  • 3. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 4. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B, Schonewille H, Ndugwa C, Brand A.
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [Abstract] [Full Text] [Related]

  • 5. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
    Kalyanaraman M, Heidemann SM, Sarnaik AP, Meert KL, Sarnaik SA.
    J Pediatr Hematol Oncol; 1999 Jan; 21(1):70-3. PubMed ID: 10029818
    [Abstract] [Full Text] [Related]

  • 6. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV, Steane E, Cunningham G, Frenkel EP.
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [Abstract] [Full Text] [Related]

  • 7. Hyperhemolysis syndrome in anemia of chronic disease.
    Darabi K, Dzik S.
    Transfusion; 2005 Dec; 45(12):1930-3. PubMed ID: 16371046
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ, Shenoy S, Goodnough LT.
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [Abstract] [Full Text] [Related]

  • 9. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C, Ohto H, Miura S, Yasuda H, Ono S, Ogata T.
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [Abstract] [Full Text] [Related]

  • 10. The effects of cryopreservation on red blood cell microvesiculation, phosphatidylserine externalization, and CD47 expression.
    Holovati JL, Wong KA, Webster JM, Acker JP.
    Transfusion; 2008 Aug; 48(8):1658-68. PubMed ID: 18482179
    [Abstract] [Full Text] [Related]

  • 11. Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling.
    Bourgeaux V, Hequet O, Campion Y, Delcambre G, Chevrier AM, Rigal D, Godfrin Y.
    Transfusion; 2010 Oct; 50(10):2176-84. PubMed ID: 20456710
    [Abstract] [Full Text] [Related]

  • 12. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V.
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [Abstract] [Full Text] [Related]

  • 13. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
    Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW.
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [Abstract] [Full Text] [Related]

  • 14. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.
    Elenga N, Mialou V, Kebaïli K, Galambrun C, Bertrand Y, Pondarre C.
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):928-30. PubMed ID: 19131783
    [Abstract] [Full Text] [Related]

  • 15. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
    McPherson ME, Anderson AR, Haight AE, Jessup P, Castillejo MI, Hillyer CD, Josephson CD.
    Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
    [Abstract] [Full Text] [Related]

  • 16. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL.
    Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
    [Abstract] [Full Text] [Related]

  • 17. To RBC or not to RBC: the role of suicidal death in hemolytic transfusion reactions.
    Zimring JC, Spitalnik SL.
    Transfusion; 2009 Sep; 49(9):1776-8. PubMed ID: 19735500
    [No Abstract] [Full Text] [Related]

  • 18. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.
    Tournamille C, Meunier-Costes N, Costes B, Martret J, Barrault A, Gauthier P, Galactéros F, Nzouékou R, Bierling P, Noizat-Pirenne F.
    Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340
    [Abstract] [Full Text] [Related]

  • 19. Hemolytic transfusion reaction after preoperative prophylactic blood transfusion for sickle cell disease in pregnancy.
    Proudfit CL, Atta E, Doyle NM.
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):471-4. PubMed ID: 17666632
    [Abstract] [Full Text] [Related]

  • 20. Cerebrovascular accident during a delayed hemolytic transfusion reaction in a patient with sickle cell anemia.
    Mintz PD, Williams ME.
    Ann Clin Lab Sci; 1986 Aug; 16(3):214-8. PubMed ID: 3717883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.